PATENT CLAIM ANALYSIS

Application Number: 15768025
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.

Claim (Index 36):
Compounds as defined in any one of the preceding claims for the use as ferroportin inhibitors for the use in an adjunctive therapy by limiting the amount of iron available to pathogenic microorganisms, such as the bacterium  Vibrio vulnificus , thereby treating infections caused by said pathogenic microorganisms.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.25532
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15769148', '14310254', '15517528', '14007533', '15185186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.79159184666035
- 35 USC 102 Novelty (BERT): 0.5467461433212601
- Combined Prediction Score: 0.767107276326441
- Mean Citation Score: 298.633386
- Max Citation Score: 422.5474
- Similarity Product: 255.84166392936703

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test